Scarica l'app Stockscreener
36.01
3.64%
-1.36
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché TGTX Giù?
Forum
Previsione
Frazionamento azionario
Tg Therapeutics Inc Borsa (TGTX) Ultime notizie
TG Therapeutics shareholders approve key proposals By Investing.com - Investing.com South Africa
TG Therapeutics Approves Key Proposals at Annual Meeting - TipRanks
TG Therapeutics shareholders approve key proposals - Investing.com
TG Therapeutics at Goldman Sachs Conference: Strategic Growth and Innovations - Investing.com Canada
Transcript : TG Therapeutics, Inc. Presents at Goldman Sachs 46th Annual Global Healthcare Conference 2025, Jun-10-2025 10 - marketscreener.com
GAMMA Investing LLC Purchases 176,573 Shares of TG Therapeutics, Inc. (NASDAQ:TGTX) - Defense World
TG Therapeutics to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference - GlobeNewswire
TG Therapeutics to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference | TGTX Stock News - GuruFocus
TG Therapeutics (NasdaqCM:TGTX) Stock Rises 13% In Last Month - Yahoo
Kalkine: TG Therapeutics Schedules Fireside Chat at Goldman Sachs Conference Amid FT100 Futures Focus - Kalkine Media
TG Therapeutics CEO Fireside Chat at Goldman's Premier Healthcare Conference: Key Updates Coming - Stock Titan
Two Sigma Advisers LP Sells 214,800 Shares of TG Therapeutics, Inc. (NASDAQ:TGTX) - Defense World
LAWSUITS FILED AGAINST U, TGTX and CVNAJakubowitz Law Pursues Shareholders Claims - ACCESS Newswire
Transcript : TG Therapeutics, Inc. Presents at Jefferies Global Healthcare Conference 2025, Jun-04-2025 12 - marketscreener.com
(TGTX) Investment Analysis and Advice - news.stocktradersdaily.com
TG Therapeutics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference - The Globe and Mail
TG Therapeutics to Participate in the Jefferies Global Healthcare Conference - The Manila Times
TG Therapeutics CEO Fireside Chat: Key Updates Expected at Major Healthcare Conference - Stock Titan
TG Therapeutics shares MS drug trial updates By Investing.com - Investing.com South Africa
TG Therapeutics Announces Data Presentations for BRIUMVI in Mult - GuruFocus
TG Therapeutics shares MS drug trial updates - Investing.com
TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the 2025 Consortium of Multiple Sclerosis Centers Annual Meeting | TGTX Stock News - GuruFocus
TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the 2025 Consortium of Multiple Sclerosis Centers Annual Meeting - The Manila Times
TG Therapeutics Announces Data Presentations for BRIUMVI in - GlobeNewswire
TG Therapeutics: Estimates Could Soon Be Raised Again (NASDAQ:TGTX) - Seeking Alpha
Man Group plc Purchases Shares of 9,589 TG Therapeutics, Inc. (NASDAQ:TGTX) - Defense World
TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® in Multiple Sclerosis at the 2025 Consortium of Multiple Sclerosis Centers Annual Meeting | TGTX Stock News - GuruFocus
TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® in Multiple Sclerosis at the 2025 Consortium of Multiple Sclerosis Centers Annual Meeting - The Manila Times
TG Therapeutics Announces Schedule of Data Presentations - GlobeNewswire
TG Therapeutics Announces Schedule of Data Presentations for BRIUMVI® in Multiple Sclerosis at ... - Eagle-Tribune
Bank of America Corp DE Has $6.95 Million Stake in TG Therapeutics, Inc. (NASDAQ:TGTX) - Defense World
How To Trade (TGTX) - news.stocktradersdaily.com
Captrust Financial Advisors Sells 22,765 Shares of TG Therapeutics, Inc. (NASDAQ:TGTX) - Defense World
Exploring 3 High Growth Tech Stocks In The US Market - Yahoo Finance
TG Therapeutics, Inc. (NASDAQ:TGTX) Given Consensus Rating of “Moderate Buy” by Brokerages - Defense World
TG Therapeutics, Inc. (NASDAQ:TGTX) Shares Sold by BNP Paribas Financial Markets - Defense World
TG Therapeutics' (NASDAQ:TGTX) Weak Earnings May Only Reveal A Part Of The Whole Picture - simplywall.st
Investor Calendar Invites You to the TG Therapeutics, Inc. Third Quarter 2016 Earnings Conference Call and Webcast Live on Monday, November 7, 2016 - ACCESS Newswire
(TGTX) Long Term Investment Analysis - news.stocktradersdaily.com
TG Therapeutics Boosts Retail Sentiment With Q1 Revenue Beat Even As Stock Tumbles On Profit Miss, Conservative Outlook - MSN
Decoding TG Therapeutics Inc (TGTX): A Strategic SWOT Insight - GuruFocus
TG Therapeutics, Inc. (TGTX): Among the Best Cancer Stocks to Invest in for Long-Term Gain - Insider Monkey
10 Best Cancer Stocks to Invest in for Long-Term Gains - Insider Monkey
TG Therapeutics raises 2025 guidance to $560M, driven by BRIUMVI adoption - MSN
TG Therapeutics stock sinks on profit miss - MSN
TG Therapeutics Q1 2025 Earnings Call Transcript - MarketBeat
TG Therapeutics, Inc. (NASDAQ:TGTX) Q1 2025 Earnings Call Transcript - Insider Monkey
TG Therapeutics First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags - Yahoo Finance
TG Therapeutics Inc (TGTX) Q1 2025 Earnings Call Highlights: Str - GuruFocus
Jefferies maintains Buy on TGTX stock with $46 target By Investing.com - Investing.com Nigeria
TG Therapeutics Inc (TGTX) Q1 2025 Earnings Call Highlights: Strong BRIUMVI Sales and Increased ... - Yahoo Finance
1.91%
1.17%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):